Logo-BCC-Research.jpg
Gene Modification Therapy Market to See 49.9% Annual Growth Through 2023
September 18, 2018 06:00 ET | BCC Research
WELLESLEY, Mass., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Recent advancements in genetic modification, including better delivery systems, more efficient and durable gene expression constructs, and...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership
July 18, 2018 08:00 ET | Taconic Biosciences
RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated...
Synthego Named One of World’s Top 10 Most Innovative Companies in Biotech by Fast Company
February 20, 2018 12:03 ET | Synthego
REDWOOD CITY, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Synthego, a leading provider of genome engineering solutions, today announced it has been named one of the Top 10 Most Innovative Companies in...
Poseida.jpg
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
February 05, 2018 08:00 ET | Poseida Therapeutics, Inc.
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies,...
Synthego Launches Powerful CRISPR Analysis Software To Make World-Class Genome Engineering Accessible
January 29, 2018 09:04 ET | Synthego
REDWOOD CITY, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Synthego, a leading provider of genome engineering solutions, announces today the launch of ICE, a powerful new tool named “Inference of...
Synthego Introduces First CRISPR Guaranteed Editing Genome Engineering Solution
December 14, 2017 09:02 ET | Synthego
REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Synthego, a leading provider of genome engineering solutions, announces the launch of its new CRISPRevolution™ Gene Knockout Kit (GKO) with...
CRISPR_Logo.jpg
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
August 22, 2017 07:30 ET | CRISPR Therapeutics AG
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
August 14, 2017 09:00 ET | Taconic Biosciences
HUDSON, N.Y., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
August 08, 2017 16:43 ET | Taconic Biosciences
HUDSON, N.Y., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement...
CRISPR_Logo.jpg
CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing
March 28, 2017 08:00 ET | CRISPR Therapeutics AG
- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE...